Osteoporosis in inflammatory joint diseases

Osteoporosis International

Volumn 22, Issue 2, 2011, Pages 421-433

  Roux, C ^a  

^a NONE

Author keywords

Ankylosing spondylitis; Bone formation; Bone resorption; Osteoporosis; Rheumatoid arthritis; Vertebral fracture

Indexed keywords

ADALIMUMAB; BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN; C REACTIVE PROTEIN; DENOSUMAB; GLUCOCORTICOID; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOPROTEGERIN; PLACEBO; PREDNISONE; RHEUMATOID FACTOR; SCLEROSTIN; TUMOR NECROSIS FACTOR ANTIBODY;

ANALGESIA; ANKYLOSING SPONDYLITIS; BACKACHE; BODY FAT; BONE DENSITY; BONE EROSION; BONE INJURY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FIBULA FRACTURE; FUNCTIONAL DISEASE; GENE EXPRESSION; HAND BONE; HEREDITY; HIP FRACTURE; HUMAN; HUMERUS FRACTURE; KYPHOSIS; MUSCLE ATROPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFICATION; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PELVIS FRACTURE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RIGIDITY; RISK FACTOR; SYNOVITIS; TIBIA FRACTURE; VERTEBRA FRACTURE; WRIST FRACTURE;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BONE DENSITY; BONE RESORPTION; FEMALE; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; OSTEOGENESIS; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; RISK FACTORS; SPINAL FRACTURES; SPONDYLITIS, ANKYLOSING;

EID: 78651484697     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1319-x     Document Type: Review

References (115)

1. TP van Staa P Geusens WJ Bijlsma HGM Leufkens C Cooper 2006 Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis Arthritis Rheum 54 3104 3112 17009229 10.1002/art.22117
2. RE Orstavik G Haugeberg T Uhlig P Mowinckel JA Falch JI Halse, et al. 2004 Self reported non-vertebral fractures in rheumatoid arthritis and population based controls: incidence and relationship with bone mineral density and clinical variables Ann Rheum Dis 63 177 182 1:STN:280: DC%2BD2c%2Fit1Olsg%3D%3D 14722207 10.1136/ard.2003.005850
3. TM Huusko M Korpela P Karppi V Avikainen H Kautiainen R Sulkava 2001 Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland Ann Rheum Dis 60 521 522 1:STN:280:DC%2BD3M3oslyisg%3D%3D 11302878 10.1136/ard.60.5.521
4. JR Hooyman LJ Melton AM Nelson WM O'Fallon BL Riggs 1984 Fractures after rheumatoid arthritis Arthritis Rheum 27 1353 1361 1:STN:280: DyaL2M%2Fnt1elsA%3D%3D 6508860 10.1002/art.1780271205
5. RE Orstavik G Haugeberg P Mowinckel A Hoiseth T Uhlig JA Falch JI Halse E Mc Closkey TK Kvien 2004 Vertebral deformities in rheumatoid arthritis Arch Intern Med 164 420 425 14980993 10.1001/archinte.164.4.420
6. RNJ de Nijs JWG Jacobs JWJ Bijlsma WF Lems RFJM Laan HHM Houben EJ ter Borg AM Huisman GAW Bruyn PLM van Oijen AAA Westgeest A Algra DM Hofman on behalf of the Osteoporosis Working Group of the Dutch Society for Rheumatology 2001 Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis Rheumatology 40 1375 1383 11752508 10.1093/rheumatology/40.12.1375
7. TD Spector GM Hall EV Mc Closkey JA Kanis 1993 Risk of vertebral fracture in women with rheumatoid arthritis BMJ 306 558 1:STN:280:DyaK3s3hsVCqsA%3D%3D 8461772 10.1136/bmj.306.6877.558
8. NF Pell DJ Moore NA Barrington DE Bax R Eastell 1995 Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis Ann Rheum Dis 54 801 806 10.1136/ard.54.10.801
9. RE Orstavik G Haugeberg T Uhlig P Mowinckel JA Falch JI Halse T Kvien 2005 Incidence of vertebral deformities in 255 female rheumatoid arthritis patients measured by morphometric X-ray absorptiometry Osteoporos Int 16 35 42 15197538 10.1007/s00198-004-1631-4
10. MC Lodder G Haugeberg WF Lems T Uhlig RE Orstavik PJ Kostense, et al. 2003 Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative study Arthritis Rheum 49 209 215 12687512 10.1002/art.10996
11. WF Lems ZN Jahangier JWG Jacobs JWJ Bijlsma 1995 Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroids Clin Exp Rheumatol 13 293 297 1:STN:280:DyaK28%2FksVGgsg%3D%3D 7554554
12. J Ursum K Britsemmer D van Schaardenburg PTA Lips BAC Dijkmans W Lems 2009 High prevalence of vertebral deformities in elderly patients with early rheumatoid arthritis Ann Rheum Dis 68 1512 1513 1:STN:280:DC%2BD1MrltFOktA%3D%3D 19674990 10.1136/ard.2008.105957
13. L Sinigaglia A Nervetti Q Mela G Bianchi A Del Puente O Di Munno B Frediano F Cantatore R Pellerito S Bartolone G La Montagna S Adami 2000 High prevalence of vertebral deformities in elderly patients with early rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis J Rheumatol 27 2582 2589 1:STN:280:DC%2BD3M7otVOksg%3D%3D 11093437
14. E Smulders C Schreven V Weerdesteyn, et al. 2009 Fall incidence and fall risk factors in people with rheumatoid arthritis Ann Rheum Dis 68 1795 1796 1:STN:280:DC%2BD1MnosF2guw%3D%3D 19822719 10.1136/ard.2009.109009
15. Hayashibara M, Hagino H, Katagiri H, Okano T, Okada J, Teshima R (2010) Incidence and risk factors of falling in ambulatory patients with rheumatoid arthritis: a prospective 1-year study. Osteoporos Int. doi: 10.1007/s00198-009- 1150-4
16. M Jamison GB Neuberger PA Miller 2003 Correlates of falls and fear of falling among adults with rheumatoid arthritis Arthritis Rheum 49 673 680 14558053 10.1002/art.11383
17. R Roubenoff RA Roubenoff JG Cannon JJ Kehayias H Zhuang B Dawson-Hughes, et al. 1994 Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation J Clin Invest 93 2379 2386 1:STN:280:DyaK2c3lvFOqtg%3D%3D 8200971 10.1172/JCI117244
18. JT Giles SM Ling L Ferrucci SJ Bartlett RE Andersen M Towns D Muller KR Fontaine JM Bathon 2008 Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies Arthritis Rheum 59 807 815 18512711 10.1002/art.23719
19. V Matschke P Murphy AB Lemmey PJ Maddison JM Thom 2010 Muscle quality, architecture, and activation in cachetic patients with rheumatoid arthritis J Rheumatol 37 282 284 20008916 10.3899/jrheum.090584
20. SM Marcora KR Chester G Mittal AB Lemmey PJ Maddison 2006 Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis Am J Clin Nutr 84 1463 1472 1:CAS:528: DC%2BD28XhtlGrurnP 17158431
21. SM Marcora AB Lemmey PJ Maddison 2005 Can progressive resistance training reverse cachexia in patients with rheumatoid arthritis? Results of a pilot study J Rheumatol 32 1031 1039 15940763
22. RE Orstavik G Haugeberg T Uhlig JA Falch JI Halse A Hoiseth F Lilleas TK Kvien 2003 Vertebral deformities in 229 female patients with rheumatoid arthritis: associations with clinical variables and bone mineral density Arthritis Rheum 3 355 360 10.1002/art.11118
23. G Haugeberg T Uhlig JA Falch JI Halse TK Kvien 2000 Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis Arthritis Rheum 43 522 530 1:STN:280:DC%2BD3c7ptFSrug%3D%3D 10728744 10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y
24. JC Martin R Munro MK Campbell DM Reid 1997 Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements Br J Rheumatol 36 43 49 1:STN:280:DyaK2s3ivVektw%3D%3D 9117173 10.1093/rheumatology/36.1.43
25. GM Hall TD Spector AJ Griffin ASM Jawad ML Hall DV Doyle 1993 The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women Arthritis Rheum 36 1510 1516 1:STN:280:DyaK2c%2FlvFWqsg%3D%3D 8240428 10.1002/art.1780361105
26. PN Sambrook JA Eisman GD Champion MG Yeates NA Pocock S Eberl 1987 Determinants of axial bone loss in rheumatoid arthritis Arthritis Rheum 30 721 728 1:STN:280:DyaL2s3pvVKnsQ%3D%3D 3619959 10.1002/art.1780300701
27. H Kroger R Honkanen S Saarikoski E Alhava 1994 Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis-a population based study Ann Rheum Dis 53 18 23 1:STN:280:DyaK2c7ksFWrsg%3D%3D 8311549 10.1136/ard.53.1.18
28. G Haugeberg T Uhlig JA Falch JI Halse TK Kvien 2000 Reduced bone mineral density in male rheumatoid arthritis patients Arthritis Rheum 43 2776 2784 1:STN:280:DC%2BD3M%2FnvFylsg%3D%3D 11145036 10.1002/1529-0131(200012)43: 12<2776::AID-ANR18>3.0.CO;2-N
29. AK Gough J Lilley S Eyre RL Holder P Emery 1994 Generalised bone loss in patients with early rheumatoid arthritis Lancet 344 23 27 1:STN:280: DyaK2c3osFGruw%3D%3D 7912297 10.1016/S0140-6736(94)91049-9
30. MC Lodder Z de Jong PJ Kostense ETH Molenaar K Staal AE Voskuyl JMW Hazes BAC Dijkmans WF Lems 2004 Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density Ann Rheum Dis 63 1576 1580 1:STN:280:DC%2BD2crntl2luw%3D%3D 15547081 10.1136/ard.2003.016253
31. M Güler-Yüksel J Bijsterbosch YPM Goekoop-Ruiterman JK de Vries-Bouwstra HK Ronday AJ Peeters JM de Jonge-Bok FC Breedveld BAC Dijkmans CF Allaart WF Lems 2007 Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis Ann Rheum Dis 66 1508 1512 17456523 10.1136/ard.2007.070839
32. K Forslind C Keller B Svensson I Hafstrom 2003 Reduced bone mineral density in early rheumatoid arthritis is associated with radiological joint damage at baseline and after 2 years in women J Rheumatol 30 2590 2596 14719199
33. EJJA Kroot MG Nieuwenhuizen MC de Waal Malefijt PLCM van Riel PCM van Pasker-de Jong RFJM Laan 2001 Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease Arthritis Rheum 44 1254 1260 1:STN:280:DC%2BD3MzksVOgsg%3D%3D 11407683 10.1002/1529-0131(200106)44: 6<1254::AID-ART216>3.0.CO;2-G
34. F Chopin P Garnéro A le Henanff F Debiais A Daragon C Roux J Sany D Wendling C Zarnitsky P Ravaud T Thomas 2008 Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis Ann Rheum Dis 67 353 357 1:CAS:528:DC%2BD1cXjs1ejs7w%3D 17644538 10.1136/ard.2007.076604
35. G Haugeberg PG Conaghan M Quinn P Emery 2009 Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study Ann Rheum Dis 68 1898 1901 1:CAS:528:DC%2BD1MXhsF2itrzF 19386610 10.1136/ard.2008.106484
36. M Vis EA Havaardsholm G Haugeberg T Uhlig AE Voskuyl RJ van de Stadt BAC Dijkmans AD Woolf TK Kvien WF Lems 2006 Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis Ann Rheum Dis 65 1495 1499 1:CAS:528:DC%2BD28Xht1OjtL3E 16606653 10.1136/ard.2005.044198
37. CA Wijbrandts R Klaasen MGW Dijkgraaf DM Gerlag BLF van Eck-Smit PP Tak 2009 Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss Ann Rheum Dis 68 373 376 1:CAS:528:DC%2BD1MXjs1WitLg%3D 18408246 10.1136/ard.2008.091611
38. G Haugeberg A Strand TK Kvien, et al. 2005 Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo controlled trial Arch Intern Med 165 1293 1297 15956010 10.1001/archinte.165.11.1293
39. NFA Peel AJ Spittlehouse DE Bax R Eastell 1994 Bone mineral density of the hand in rheumatoid arthritis Arthritis Rheum 5 983 991 10.1002/art. 1780370702
40. AA Deodhar J Brabyn I Pande DL Scott AD Woolf 2003 Hand bone densitometry in rheumatoid arthritis, a five year longitudinal study: an outcome measure and a prognostic marker Ann Rheum Dis 62 767 770 1:STN:280:DC%2BD3szjtVWisQ%3D%3D 12860734 10.1136/ard.62.8.767
41. G Haugeberg MJ Green MA Quinn H Marzo-Ortega S Proudman Z Karim RJ Wakefield PG Conaghan S Stewart P Emery 2006 Hand bone loss in early undifferentiated arthritis: evaluating bone mineral density loss before the development of rheumatoid arthritis Ann Rheum Dis 65 736 740 1:STN:280:DC%2BD283mslCmsw%3D%3D 16284095 10.1136/ard.2005.043869
42. T Jensen M Klarlund M Hansen KE Jensen J Podenphant TM Hansen H Skjodt L Hydstrup 2004 Bone loss unclassified polyarthritis and early rheumatoid arthritis is better detected by digital X-ray radiogrammetry than dual X-ray absorptiometry: relationship with disease activity and radiographic outcome Ann Rheum Dis 63 15 22 1:STN:280:DC%2BD2c%2FhtV2jtw%3D%3D 14672886 10.1136/ard.2003.013888
43. J Bottcher A Pfeil A Rosholm A Petrovitch BE Seidl A Malich ML Schafer A Kramer HJ Mentzel G Lehmann, et al. 2005 Digital X-ray radiogrammetry combined with semiautomated analysis of joint space widths as a new diagnostic approach in rheumatoid arthritis: a cross-sectional and longitudinal study Arthritis Rheum 52 3850 3859 1:STN:280:DC%2BD2MnlsFGksA%3D%3D 16320332 10.1002/art.21606
44. G Haugeberg MJ Green PG Conaghan M Quinn R Wakefield SM Proudman S Stewart E Hensor P Emery 2007 Hand bone densitometry: a more sensitive standard for the assessment of early bone damage in rheumatoid arthritis Ann Rheum Dis 66 1513 1517 1:CAS:528:DC%2BD2sXhtlGrtL%2FO 17491097 10.1136/ard.2006.067652
45. M Hoff G Haugeberg TK Kvien 2007 Hand bone loss as an outcome measure in established rheumatoid arthritis: 2-year observational study comparing cortical and total bone loss Arthritis Res Ther 9 1 8 10.1186/ar2280
46. FE Alenfeld E Diessel M Brezger J Sieper D Felsenberg J Braun 2000 Detailed analyses in periarticular osteoporosis in rheumatoid arthritis Osteoporos Int 11 400 407 1:STN:280:DC%2BD3cvgvFelug%3D%3D 10912841 10.1007/s001980070106
47. E Lindqvist K Jonsson T Saxne K Eberhardt 2003 Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis Ann Rheum Dis 62 611 616 1:STN:280:DC%2BD3s3ot1Ggtg%3D%3D 12810421 10.1136/ard.62.7.611
48. M Hoff G Haugeberg S Odegard S Syversen R Landewé D van der Heijde TK Kvien 2009 Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up Ann Rheum Dis 68 324 329 1:STN:280:DC%2BD1M7js1OgsA%3D%3D 18339664 10.1136/ard.2007.085985
49. M Güler-Yüksel CF Allaart YPM Goekoop-Ruiterman JK de Vries-Bouwstra JHLM van Groenendael C Mallée MHW de Bois FC Breedveld BAC Dijkmans WF Lems 2009 Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis Ann Rheum Dis 68 330 336 18375540 10.1136/ard.2007.086348
50. P Boyesen M Hoff S Odegard G Haugeberg SW Syversen PI Gaarder C Okkenhaug TK Kvien 2009 Antibodies to cyclic citrillunated protein and ESR predict hand bone loss in patients with RA of short duration Arthritis Res Ther 11 R103 19570223 10.1186/ar2749 1:CAS:528:DC%2BD1MXotlers7c%3D
51. CM Stach M Bäuerle M Englbrecht G Kronke K Engelke B Manger G Schett 2010 Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high-resolution computed tomography Arthritis Rheum 62 330 339 20112404
52. ET Molenaar AE Voskuyl HJ Dinant PD Bezemer M Boers BA Dijkmans 2004 Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission Arthritis Rheum 50 36 42 14730597 10.1002/art.11481
53. G Schett S Kiechl S Weger A Pederiva A Mayr M Petrangeli F Oberhollenzer R Lorenzini K Redlich R Axmann J Zwerina J Willeit 2006 High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study Arch Intern Med 166 2495 2501 1:CAS:528:DC%2BD2sXls1ygsg%3D%3D 17159016 10.1001/archinte.166.22.2495
54. C Ding V Parameswaran R Udayan J Burgess G Jones 2008 Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study J Clin Endocrinol Metab 93 1952 1958 1:CAS:528:DC%2BD1cXlvFWgtrc%3D 18285417 10.1210/jc.2007-2325
55. JA Cauley ME Danielson RM Boudreau KYZ Forrest J Zmuda M Pahor FA Tylavsky SR Cummings TB Harris AB Newman for the Health ABC study 2007 Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study J Bone Miner Res 22 1088 1095 1:CAS:528:DC%2BD2sXpt1Kntrc%3D 17419681 10.1359/jbmr.070409
56. N Charactcharoenwitthaya S Khosla EJ Atkinson LK McCready BL Riggs 2007 Effect of blockade of TNF-α and interleukin-1 action on bone resorption in early postmenopausal women J Bone Miner Res 22 724 729 10.1359/jbmr.070207
57. B Cortet RM Flipo P Pigny B Duquesnoy A Boersma X Marchandise B Delcambre 1998 Is bone turnover a determinant of bone mass in rheumatoid arthritis? J Rheumatol 25 2339 2344 1:STN:280:DyaK1M%2FnsVWgug%3D%3D 9858427
58. A Gough P Sambrook J Devlin A Huissoon C Njeh S Robbins T Nguyen P Emery 1998 Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis J Rheumatol 25 1282 1289 1:STN:280:DyaK1czjvFekuw%3D%3D 9676757
59. P Garnéro R Landewe M Boers A Verhoeven S van der Linden S Christgau D van der Heijde A Boonen P Geusens 2002 Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis. The Cobra Study Arthritis Rheum 46 2847 2856 12428224 10.1002/art.10616 1:CAS:528: DC%2BD38XptlSlu7c%3D
60. PP Geusens RBM Landewé P Garnéro D Chen CR Dunstan WF Lems P Stinissen DMFM van der Heijde S van der Linden M Boers 2006 The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction Arthritis Rheum 54 1772 1777 1:CAS:528: DC%2BD28Xms1Sjtbw%3D 16736519 10.1002/art.21896
61. K Redlich S Hayer R Ricci JP David M Tohidast-Akrad G Kollias G Steiner JS Smolen EF Wagner G Schett 2002 Osteoclasts are essential for TNF-alpha-mediated joint destruction J Clin Invest 110 1419 1427 1:CAS:528:DC%2BD38XovFOnu7s%3D 12438440
62. E Jimenez-Boj K Redlich B Türk H Hanslik-Schnabel A Wanivenhaus A Chott JS Smolen G Schett 2005 Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis J Immunol 175 2579 2588 1:CAS:528:DC%2BD2MXntVSqs7Y%3D 16081832
63. YY Kong U Feige I Sarosi B Bolon A Tafuri S Morony, et al. 1999 Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoproteogerin ligand Nature 402 304 309 1:CAS:528:DyaK1MXnvFShsLg%3D 10580503 10.1038/46303
64. MM Zaiss R Axmann J Zwerina K Polzer E Gückel A Skapenko H Schulze-Koops N Horwood A Cope G Schett 2007 Treg cells suppress ostoclast formation. A new link between the immune system and bone Arthritis Rheum 56 4104 4112 1:CAS:528:DC%2BD1cXnt1Oktw%3D%3D 18050211 10.1002/art.23138
65. R Axmann S Herman M Zaiss S Franz K Polzer J Zwerina M Hermann J Smolen G Schett 2008 CTLA-4 directly inhibits osteoclast formation Ann Rheum Dis 67 1603 1609 1:CAS:528:DC%2BD1cXhtl2gsbfI 18203760 10.1136/ard.2007.080713
66. K Sato A Suematsu K Okamoto A Yamaguchi Y Morishita Y Kadono S Tanaka T Kodama S Akira Y Iwakura DJ Cua 2006 Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction J Exp Med 203 2673 2682 1:CAS:528:DC%2BD28Xht12htLfJ 17088434 10.1084/jem.20061775
67. AR Pettit NC Walsh C Manning SR Goldring EM Gravallese 2006 RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis Rheumatology 45 1068 1076 1:CAS:528:DC%2BD28XhtVWlt7fP 16490750 10.1093/rheumatology/kel045
68. C Li XQ Wei B Evans W Jiang D Aeschlimann 2008 IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-kb (RANK) expression in myeloid precursor cells Eur J Immunol 38 2845 2854 10.1002/eji.200838192 1:CAS:528:DC%2BD1cXhtlOjsL7K
69. S Herman R Mueller G Kronke J Zwerina K Redlich A Hueber H Gelse E Neumann U Mueller-Ladner G Schett 2008 OSCAR, a key co-stimulation molecule for osteoclasts, is induced in patients with rheumatoid arthritis Arthritis Rheum 58 3041 3050 1:CAS:528:DC%2BD1cXht12rurzN 18821671 10.1002/art.23943
70. G Schett K Redlich S Hayer, et al. 2003 Osteoproteogerin protects against generalized bon loss in tumor necrosis factor-transgenic mice Arthritis Rheum 48 2042 2051 1:CAS:528:DC%2BD3sXmtFartbY%3D 12847699 10.1002/art.11150
71. J Lam S Takeshita JE Barker O Kanagawa FP Ross SL Teitelbaum 2000 TNFα induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligang J Clin Invest 106 1481 1488 1:CAS:528:DC%2BD3cXovFagtbo%3D 11120755 10.1172/JCI11176
72. K Polzer L Joosten J Gasser JH Distler G Ruiz W Baum K Redlich K Bobacz JS Smolen W van den Berg G Schett J Zwerina 2010 Interleudin-1 is essential for systemic inflammatory bone loss Ann Rheum Dis 69 284 290 1:CAS:528: DC%2BC3cXhtFOlsb8%3D 19196726 10.1136/ard.2008.104786
73. D Diarra M Stolina K Polzer J Zwerina MS Ominsky D Dwyer A Korb J Smolen M Hoffmann C Scheinecker D van der Heide R Landewé D Lacey WG Richard G Schett 2007 Dickkopf-1 is a master regulator of joint remodeling Nat Med 13 156 163 1:CAS:528:DC%2BD2sXhsVyktbY%3D 17237793 10.1038/nm1538
74. NC Walsh S Reinwald CA Manning KW Condon K Iwata DB Burr EM Gravallese 2009 Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis J Bone Miner Res 24 1572 1585 1:CAS:528: DC%2BD1MXht1Wju7%2FK 19338457 10.1359/jbmr.090320
75. R Axmann C Böhm G Krönke J Zwerina J Smolen G Schett 2009 Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo Arthritis Rheum 60 2747 2756 1:CAS:528:DC%2BD1MXht1WhtLbJ 19714627 10.1002/art.24781
76. N Saidenberg-Kermanac'h A Corrado D Lemeiter MC de Vernejoul MC Boissier M Cohen-Solal 2004 TNF-α antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis Bone 35 1200 1207 15542046 10.1016/j.bone.2004.07.004 1:CAS:528:DC%2BD2cXpslOqtLY%3D
77. M Stolina G Schett D Dwyer S Vonderfecht S Middleton D Duryea E Pacheco G Van B Bolon U Feige D Zack P Kostenuik 2009 RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFα or anti-IL-1 therapies Arthritis Res Ther 11 11 15 10.1186/ar2879 1:CAS:528: DC%2BD1MXhsFKqsLrL
78. D Haynes T Crotti H Weedon J Slavotinek V Au M Coleman PJ Roberts-Thomson M Ahern MD Smith 2008 Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease-modifying antirheumatic drug treatment and correlation with radiologic outcome Arthritis Rheum 59 911 920 1:CAS:528:DC%2BD1cXpt1egtLs%3D 18576301 10.1002/art.23818
79. SB Cohen RK Dore NE Lane PA Ory CG Peterfy JT Sharp D van der Heijde L Zhou W Tsuji R Newmark on behalf of the Denosumab Rheumatoid Arthritis Study Group 2008 Denosumab treatment effects on strutural damage, bone mineral density, and bone turnover in rheumatoid arthritis Arthritis Rheum 58 1299 1309 1:CAS:528:DC%2BD1cXms1ehu70%3D 18438830 10.1002/art.23417
80. R Will R Palmer AK Bhalla F Ring A Calin 1989 Osteoporosis in early ankylosing spondylitis. A primary pathological event? Lancet ii 1483 1485 10.1016/S0140-6736(89)92932-2
81. JF Maillefert S Aho A El Maghraoui M Dougados C Roux 2001 Changes in bone density in patients with ankylosing spondylitis: a 2 year follow-up study Osteoporos Int 12 605 609 1:STN:280:DC%2BD3MvosFanuw%3D%3D 11527060 10.1007/s001980170084
82. P Geusens D Vosse DM van der Heijde, et al. 2001 High prevalence of thoracic vertebral deformities and discal wedging in ankylosing spondylitis patients with hyperkyphosis J Rheumatol 28 1856 1861 1:STN:280: DC%2BD3MvmtlahsQ%3D%3D 11508590
83. SH Raltson GDK Urquhart M Bzeski RD Sturrock 1990 Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis Br Med J 300 563 565 10.1136/bmj.300.6724.563
84. C Cooper L Carbone CJ Michet EJ Atkinson WM O'Fallon LJ Melton 1994 Fracture risk in patients with ankylosing spondylitis: a population based study J Rheumatol 21 1877 1882 1:STN:280:DyaK2M7jvV2ntw%3D%3D 7837154
85. S Donnelly DV Doyle A Denton J Rolfe EV McCloskey TD Spector 1994 Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis Ann Rheum Dis 53 117 121 1:STN:280:DyaK2c7nsFKjtw%3D%3D 8129456 10.1136/ard.53.2.117
86. D Mitra DM Elvins DJ Speden, et al. 2000 The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density Rheumatology 39 85 89 1:STN:280:DC%2BD3c7jtFWiuw%3D%3D 10662879 10.1093/rheumatology/39.1.85
87. D Vosse E Feidtkeller J Erlendsson, et al. 2004 Clinical vertebral fractures in patients with ankylosing spondylitis J Rheumatol 31 1981 1985 15468363
88. E Feldtkeller D Vosse P Geusens S van der Linden 2006 Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitis Rheumatol Int 26 234 239 15761730 10.1007/s00296-004-0556-8
89. D Vosse R Landewé D van der Heijde S van der Linden TP van Staa P Geusens 2009 Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study Ann Rheum Dis 68 1839 1842 1:STN:280:DC%2BD1MjlsFKhsA%3D%3D 19066179 10.1136/ard.2008.100503
90. JP Devogelaer B Maldague J Malghem C Nagant de Deuxchaisnes 1992 Appendicular and vertebral bone mass in ankylosing spondylitis Arthritis Rheum 35 1062 1067 1:STN:280:DyaK3s%2FjvV2hsw%3D%3D 1418022 10.1002/art.1780350911
91. JB Jun KB Joo MY Her TH Kim SC Bae DH Yoo SK Kim 2006 Femoral bone mineral density is associated with vertebral fractures in patients with ankylosing spondylitis: a cross-sectional study J Rheumatol 33 1637 1641 16881119
92. A El Maghraoui D Borderie R Edouard C Roux M Dougados 1999 Osteoporosis, body composition and bone turnover in ankylosing spondylitis J Rheumatol 26 2205 2209 1:STN:280:DyaK1Mvls1Chsg%3D%3D 10529141
93. E Toussirot F Michel D Wendling 2001 Bone density, ultrasound measurements and body composition in early ankylosing spondylitis Rheumatology 40 882 888 1:STN:280:DC%2BD3MvmslWjsw%3D%3D 11511757 10.1093/rheumatology/40.8. 882
94. I Ghozlani M Ghazi A Nouijai A Mounach A Rezqi L Achemlal A Bezza A El Maghraoui 2009 Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis Bone 44 772 776 1:STN:280:DC%2BD1MzkvFKisA%3D%3D 19442629 10.1016/j.bone.2008.12.028
95. K Karberg J Zochling J Sieper D Felsenberg J Braun 2005 Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes J Rheumatol 32 1290 1298 15996067
96. BM Obermayer-Pietsch U Lange G Tauber, et al. 2003 Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis Osteoporos Int 14 995 1000 1:CAS:528:DC%2BD3sXpvVCms70%3D 14530911 10.1007/s00198-003-1501-5
97. J Gratacos A Collado F Pons M Osaba R Sammarti M Roqué, et al. 1999 Significant loss of bone mass in patients with early, active ankylosing spondylitis. A follow-up study Arthritis Rheum 42 2319 2324 1:STN:280: DC%2BD3c%2FitFCqtQ%3D%3D 10555026 10.1002/1529-0131(199911)42:11<2319::AID- ANR9>3.0.CO;2-G
98. S Visvanathan D van der Heijde A Deodhar C Wagner DG Baker J Han J Braun 2009 Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis Ann Rheum Dis 68 175 182 1:CAS:528:DC%2BD1MXisVSjs7w%3D 18495735 10.1136/ard.2007.084426
99. F Allali M Breban R Porcher JF Maillefert M Dougados C Roux 2003 Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha Ann Rheum Dis 62 347 349 1:CAS:528: DC%2BD3sXjtVKksbs%3D 12634235 10.1136/ard.62.4.347
100. K Briot L Gossec S Kolta M Dougados C Roux 2008 Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-α treatment J Rheumatol 35 855 861 1:CAS:528:DC%2BD1cXntVOmurg%3D 18381782
101. Vosse D, Landewé R, Garnéro P, van der Heijde D, van der Linden S, Geusens P (2008) Association of markers of bone - and cartilage - degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis. Rheumatology 1-4
102. AG MacDonald G Birkinshaw B Durham RC Bucknall WD Fraser 1997 Biomedical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity Br J Rheum 36 50 53 1:STN:280:DyaK2s3ivVektA%3D%3D 10.1093/rheumatology/36.1.50
103. D Stupphann M Ranner D Krenbeck, et al. 2008 Intracellular and surface RANK L are differentially regulated in patients with ankylosing spondylitis Rheumatol Int 28 987 993 1:CAS:528:DC%2BD1cXosVCjsbo%3D 18369625 10.1007/s00296-008-0567-y
104. M Rauner D Stupphann M Haas I Fert S Glatigny W Sipos M Bréban P Pietschmann 2009 The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio J Rheumatol 36 120 126 19040304
105. WP Maksymowych P Chiowchanwisawakit T Clare SJ Pedersen M Ostergaard RGW Lambert 2009 Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis Arthritis Rheum 60 93 102 19116919 10.1002/art.24132
106. RJU Lories I Derese FP Luyten 2005 Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis J Clin Invest 115 1571 1579 1:CAS:528:DC%2BD2MXkvF2mu7c%3D 15902307 10.1172/JCI23738
107. RJ Lories I Derese JL Ceuppens FP Luyten 2003 Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by pro inflammatory cytokines, and differentially modulate fibroblast-like synoviocyte apoptosis Arthritis Rheum 48 2807 2818 1:CAS:528:DC%2BD3sXpt1Srsrw%3D 14558086 10.1002/art.11389
108. H Appel G Ruiz-Heiland J Listing J Zwerina M Herrmann R Mueller H Haibel X Baraliakos A Hempfing M Rudwaleit J Sieper G Schett 2009 Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis Arthritis Rheum 60 3257 3262 19877044 10.1002/art.24888
109. G Schett M Stolina D Dwyer D Zack S Uderhardt G Krönke P Kostenuik U Feige 2009 Tumor necrosis factor α and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis Arthritis Rheum 60 2644 2654 1:CAS:528:DC%2BD1MXht1WhtLjK 19714640 10.1002/art.24767
110. S Uderhardt D Diarra J Katzenbeisser JP David J Zwerina WG Richards G Krönke G Schett 2010 Blockade of dickkopf-1 induces fusion of sacroiliac joints Ann Rheum Dis 69 592 597 1:STN:280:DC%2BC3c7nsFChsA%3D%3D 19304568 10.1136/ard.2008.102046
111. D Daoussis SNC Liossis EE Solomou A Tsanaktsi K Bounia M Karampetsou G Yiannopoulos AP Andonopoulos 2010 Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis Arthritis Rheum 62 150 158 1:CAS:528:DC%2BC3cXhtFGnurbK 20039407 10.1002/art.27231
112. D Mc Gonagle RJ Wakefield AL Tan MA D'agostino H Toumi K Hayashi P Emery M Benjamin 2008 Distinct topography of erosion and new bone formation in Achilles tendon enthesitis. Implications for understanding the link between inflammation and bone formation in spondylarthritis Arthritis Rheum 58 2694 2699 10.1002/art.23755
113. RJU Lories I Derese C De Bari FP Luyten 2007 Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis Arthritis Rheum 56 489 497 17265484 10.1002/art.22372
114. T Iwasawa K Iwasaki T Sawada A Okada K Ueyama S Motomura S Harata I Inoue S Toh KI Furukawa 2006 Pathophysiological role of endothelin in ectopic ossification of human spinal ligaments induced by mechanical stress Calcif Tissue Int 79 422 430 1:CAS:528:DC%2BD28XhtlWntbnF 17160579 10.1007/s00223-006- 0147-7
115. GA Clines KS Mohammad Y Bao OW Stephens LJ Suva JD Shaughnessy JW Fox JM Chirgwin TA Guise 2007 Dickkopf homolog 1 mediates endothelin-1 stimulated new bone formation Mol Endocrinol 21 486 498 1:CAS:528:DC%2BD2sXhsVWisbo%3D 17068196 10.1210/me.2006-0346